Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Stoeltzing

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Current Cancer Drug Targets|August 20, 2010
Implication of heat shock protein 90 (HSP90) in tumor angiogenesis: a molecular target for anti-angiogenic therapy?Katharina Staufer, Oliver Stoeltzing
Clinical Colorectal Cancer|August 8, 2007
The direct effects of anti-vascular endothelial growth factor therapy on tumor cellsChristian Moser, Sven A Lang, Oliver Stoeltzing
Anticancer Research|June 17, 2009
Heat-shock protein 90 (Hsp90) as a molecular target for therapy of gastrointestinal cancerChristian Moser, Sven A Lang, Oliver Stoeltzing
Cancer Cell|August 15, 2006
Intracellular signaling in tumor and endothelial cells: The expected and, yet again, the unexpectedOliver Stoeltzing, Funda Meric-Bernstam, Lee M Ellis
Clinical Advances in Hematology & Oncology : H&O|September 16, 2005
Vascular endothelial growth factor receptors: expression and function in solid tumorsJane S Wey, Oliver Stoeltzing, Lee M Ellis
Cancer Research|January 28, 2004
Activator protein 2alpha inhibits tumorigenicity and represses vascular endothelial growth factor transcription in prostate cancer cellsMaribelis Ruiz, Curtis Pettaway, Renduo Song, et al.
International Journal of Clinical and Experimental Medicine|July 8, 2010
Epidemiology and survival of patients with hepatocellular carcinoma in Southern GermanyGabriele Kirchner, Georgi Kirovski, Alexandra Hebestreit, et al.
Langenbeck'S Archives of Surgery|June 10, 2009
Staged surgery with neoadjuvant 90Y-DOTATOC therapy for down-sizing synchronous bilobular hepatic metastases from a neuroendocrine pancreatic tumorOliver Stoeltzing, Martin Loss, Elisabeth Huber, et al.
Trends in Molecular Medicine|March 5, 2003
Promises and pitfalls of anti-angiogenic therapy in clinical trialsMarya F McCarty, Wenbiao Liu, Fan Fan, et al.
Cancer Research|May 6, 2004
Interleukin-1beta regulates angiopoietin-1 expression in human endothelial cellsFan Fan, Oliver Stoeltzing, Wenbiao Liu, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Current Cancer Drug Targets|August 20, 2010
Implication of heat shock protein 90 (HSP90) in tumor angiogenesis: a molecular target for anti-angiogenic therapy?Katharina Staufer, Oliver Stoeltzing
Clinical Colorectal Cancer|August 8, 2007
The direct effects of anti-vascular endothelial growth factor therapy on tumor cellsChristian Moser, Sven A Lang, Oliver Stoeltzing
Anticancer Research|June 17, 2009
Heat-shock protein 90 (Hsp90) as a molecular target for therapy of gastrointestinal cancerChristian Moser, Sven A Lang, Oliver Stoeltzing
Cancer Cell|August 15, 2006
Intracellular signaling in tumor and endothelial cells: The expected and, yet again, the unexpectedOliver Stoeltzing, Funda Meric-Bernstam, Lee M Ellis
Clinical Advances in Hematology & Oncology : H&O|September 16, 2005
Vascular endothelial growth factor receptors: expression and function in solid tumorsJane S Wey, Oliver Stoeltzing, Lee M Ellis
Cancer Research|January 28, 2004
Activator protein 2alpha inhibits tumorigenicity and represses vascular endothelial growth factor transcription in prostate cancer cellsMaribelis Ruiz, Curtis Pettaway, Renduo Song, et al.
International Journal of Clinical and Experimental Medicine|July 8, 2010
Epidemiology and survival of patients with hepatocellular carcinoma in Southern GermanyGabriele Kirchner, Georgi Kirovski, Alexandra Hebestreit, et al.
Langenbeck'S Archives of Surgery|June 10, 2009
Staged surgery with neoadjuvant 90Y-DOTATOC therapy for down-sizing synchronous bilobular hepatic metastases from a neuroendocrine pancreatic tumorOliver Stoeltzing, Martin Loss, Elisabeth Huber, et al.
Trends in Molecular Medicine|March 5, 2003
Promises and pitfalls of anti-angiogenic therapy in clinical trialsMarya F McCarty, Wenbiao Liu, Fan Fan, et al.
Cancer Research|May 6, 2004
Interleukin-1beta regulates angiopoietin-1 expression in human endothelial cellsFan Fan, Oliver Stoeltzing, Wenbiao Liu, et al.
Pageof 6